HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Danshensu inhibits β-adrenergic receptors-mediated cardiac fibrosis by ROS/p38 MAPK axis.

Abstract
Danshensu, the effective ingredient of the plant Salvia miltiorrhiza (Danshen), has been widely used for treatment of cardiovascular diseases. Cardiac fibrosis is an important process in pathological cardiac remodeling and leads to heart failure. We investigated the effect of Danshensu on β-adrenergic receptor (β-AR)-mediated cardiac fibrosis and the involved signaling transduction. Danshensu inhibited cardiofibroblast proliferation and collagen I synthesis induced by isoproterenol (ISO), a selective β-AR agonist. Phosphorylation of p38 mitogen-activated protein kinase (MAPK), which mediates ISO-induced cardiac fibrosis, was negatively regulated in this process. The negative regulation depended on the ISO inhibition of reactive oxygen species (ROS) production. Taken together, Danshensu may inhibit β-AR-mediated cardiac fibrosis by negative regulation of ROS-p38 MAPK signaling.
AuthorsHaiyan Lu, Aiju Tian, Jimin Wu, Chengzhi Yang, Rui Xing, Pu Jia, Lingjian Yang, Youyi Zhang, Xiaohui Zheng, Zijian Li
JournalBiological & pharmaceutical bulletin (Biol Pharm Bull) Vol. 37 Issue 6 Pg. 961-7 ( 2014) ISSN: 1347-5215 [Electronic] Japan
PMID24882408 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adrenergic beta-Agonists
  • Collagen Type I
  • Lactates
  • Reactive Oxygen Species
  • Receptors, Adrenergic, beta
  • 3,4-dihydroxyphenyllactic acid
  • Isoproterenol
Topics
  • Adrenergic beta-Agonists (pharmacology)
  • Animals
  • Cardiomyopathies (enzymology, metabolism, pathology, prevention & control)
  • Cell Proliferation (drug effects)
  • Cells, Cultured
  • Collagen Type I (biosynthesis)
  • Fibroblasts (drug effects, pathology)
  • Fibrosis
  • Isoproterenol (pharmacology)
  • Lactates (administration & dosage, pharmacology, therapeutic use)
  • MAP Kinase Signaling System (drug effects)
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species (metabolism)
  • Receptors, Adrenergic, beta (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: